CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 8-K Event Item 12 · Item 7
- NT 10-K Other NT 10-K
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Item 5
- 424B5 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Item 5
- REGDEX Other REGDEX
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Item 12 · Item 7
- 8-K/A Event Item 7
- REGDEX Other REGDEX
- 8-K Event Item 2 · Item 7
- 10-Q Report Quarterly Report
- 8-K Event Item 12 · Item 7
- 424B3 Offering Prospectus
Page 68 of 77 · 1,525 filings